Wound Treatments in Spain
1. EXECUTIVE SUMMARY
2. OPERATING ENVIRONMENT
2.1 OTC Registration and Classification
2.2 Vitamins & Dietary Supplements Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 De-listing or De-reimbursement
2.7 Traditional Remedies
2.8 Homeopathy
2.9 Generics
2.10 Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 2000-2005
2.11 Life Expectancy
Table 2 Life Expectancy at Birth 2000-2005
3. OTC HEALTHCARE SALES
3.1 Market Performance
Table 3 Sales of OTC Healthcare by Sector: Value 2000-2005
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
3.2 Switches
3.3 Key Trends and Developments
3.4 Competitive Environment
Table 5 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 6 OTC Healthcare Brand Shares by Retail Value 2002-2005
3.5 Leading Company Profile - Almirall Prodesfarma SA
Summary 1 Almirall Prodesfarma SA: Operational Indicators 2004
Table 7 Almirall Prodesfarma SA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.6 Leading Company Profile - Qumica Farmacutica Bayer SA
Summary 2 Qumica Farmacutica Bayer SA: Operational Indicators 2004
Table 8 Qumica Farmacutica Bayer SA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.7 Leading Company Profile - Boehringer Ingelheim Espaa SA
Summary 3 Boehringer Ingelheim Espaa SA: Operational Indicators 2003
Table 9 Boehringer Ingelheim Espaa SA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.8 Leading Company Profile - Boots Healthcare Iberia
Table 10 Boots Healthcare Iberia: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.9 Leading Company Profile - GlaxoSmithKline SA
Summary 4 GlaxoSmithKline Consumer Healthcare: Operational Indicators 2004
Table 11 GlaxoSmithKline SA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.10 Leading Company Profile - Johnson & Johnson SA
Summary 5 Johnson & Johnson SA: Operational Indicators 2004
Table 12 Johnson & Johnson SA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.11 Leading Company Profile - Merck Farma y Qumica SA
Summary 6 Merck KgaA Operational Indicators 2004
Table 13 Merck Farma y Qumica SA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.12 Leading Company Profile - Novartis Consumer Health SA
Summary 7 Novartis Consumer Health SA Operational Indicators 2004
Summary 8 Novartis Consumer Health SA: Production Statistics 2004
Table 14 Novartis Consumer Health SA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.13 Leading Companu Profile - Pfizer SA
Summary 9 Pfizer SA Operational Indicators 2003
Table 15 Pfizer SA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.14 Leading Company Profile - Productos Roche SA
Table 16 Productos Roche SA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.15 Leading Company Profile - Uriach OTC
Table 17 Uriach OTC: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.16 Leading Company Profile - Viatris Pharmaceuticals SA
Table 18 Viatris Pharmaceuticals SA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.17 Emerging and Niche Companies
3.18 Retail Distribution
Table 19 Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 20 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
3.19 Retailer Activity and Private Label Trends
Table 21 Penetration of Private Label by Sector 2001-2005
3.20 Forecast Market Performance
Table 22 Forecast Sales of OTC Healthcare by Sector: Value 2005-2010
Table 23 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2005-2010
4. WOUND TREATMENTS SALES
4.1 Sector Performance
Table 24 Sales of Wound Treatments by Subsector: Value 2000-2005
Table 25 Sales of Wound Treatments by Subsector: % Value Growth 2000-2005
Table 26 Wound Treatments Company Shares by Retail Value 2001-2005
Table 27 Wound Treatments Brand Shares by Retail Value 2002-2005
Table 28 Forecast Sales of Wound Treatments by Subsector: Value 2005-2010
Table 29 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2005-2010
4.2 New Product Developments
5. DEFINITIONS